Treatment of Levodopa-induced Dyskinesias
Abstract:
Provided herein are compositions and methods for the treatment and prevention of levodopa-induced dyskinesias (LID). In particular, M4 muscarinic receptor (M4R) positive allosteric modulators (PAMs) are administered to reduce dyskinetic behavior.
Public/Granted literature
Information query
Patent Agency Ranking
0/0